Clinical trials
Completed Pulmonary Disease, Chronic Obstructive trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
418 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 3 |
| 2003 | 6 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 13 |
| 2007 | 31 |
| 2008 | 27 |
| 2009 | 34 |
| 2010 | 37 |
| 2011 | 38 |
| 2012 | 20 |
| 2013 | 26 |
| 2014 | 36 |
| 2015 | 19 |
| 2016 | 23 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 20 |
| 2020 | 10 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 418 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 84 |
| Boehringer Ingelheim | 65 |
| AstraZeneca | 63 |
| Novartis Pharmaceuticals | 27 |
| Schön Klinik Berchtesgadener Land | 25 |
| Novartis | 15 |
| Chiesi Farmaceutici S.p.A. | 8 |
| Institut für Pneumologie Hagen Ambrock eV | 8 |
| Bayer | 6 |
| Pfizer | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 418 |
| Asthma | 28 |
| Emphysema | 17 |
| Lung Diseases | 16 |
| Bronchitis, Chronic | 10 |
| Heart Failure | 7 |
| Lung Diseases, Obstructive | 7 |
| Respiration Disorders | 6 |
| Respiratory Tract Diseases | 6 |
| Dyspnea | 5 |
Trials
Showing 1 to 25 of 418. Each trial links to its page on Pharma Observatory.
318 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.